Measuring free-living physical activity in COPD patients: Deriving methodology standards for clinical trials through a review of research studies

Bill Byrom, David A. Rowe

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

This article presents a review of the research literature to identify the methodology used and outcome measures derived in the use of accelerometers to measure free-living activity in patients with COPD. Using this and existing empirical validity evidence we further identify standards for use, and recommended clinical outcome measures from continuous accelerometer data to describe pertinent measures of sedentary behaviour and physical activity in this and similar patient populations. We provide measures of the strength of evidence to support our recommendations and identify areas requiring continued research. Our findings support the use of accelerometry in clinical trials to understand and measure treatment-related changes in free-living physical activity and sedentary behaviour in patient populations with limited activity.

LanguageEnglish
Pages172-184
Number of pages13
JournalContemporary Clinical Trials
Volume47
Early online date19 Jan 2016
DOIs
Publication statusPublished - 1 Mar 2016

Fingerprint

Chronic Obstructive Pulmonary Disease
Clinical Trials
Exercise
Research
Outcome Assessment (Health Care)
Accelerometry
Population
Therapeutics

Keywords

  • accelerometry
  • clinical trials
  • COPD
  • free-living activity
  • sedentary behaviour
  • study design

Cite this

@article{59f28b8b9d2e4dfe869e62a2daad3258,
title = "Measuring free-living physical activity in COPD patients: Deriving methodology standards for clinical trials through a review of research studies",
abstract = "This article presents a review of the research literature to identify the methodology used and outcome measures derived in the use of accelerometers to measure free-living activity in patients with COPD. Using this and existing empirical validity evidence we further identify standards for use, and recommended clinical outcome measures from continuous accelerometer data to describe pertinent measures of sedentary behaviour and physical activity in this and similar patient populations. We provide measures of the strength of evidence to support our recommendations and identify areas requiring continued research. Our findings support the use of accelerometry in clinical trials to understand and measure treatment-related changes in free-living physical activity and sedentary behaviour in patient populations with limited activity.",
keywords = "accelerometry, clinical trials, COPD, free-living activity, sedentary behaviour, study design",
author = "Bill Byrom and Rowe, {David A.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.cct.2016.01.006",
language = "English",
volume = "47",
pages = "172--184",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",

}

Measuring free-living physical activity in COPD patients : Deriving methodology standards for clinical trials through a review of research studies. / Byrom, Bill; Rowe, David A.

In: Contemporary Clinical Trials, Vol. 47, 01.03.2016, p. 172-184.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Measuring free-living physical activity in COPD patients

T2 - Contemporary Clinical Trials

AU - Byrom, Bill

AU - Rowe, David A.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - This article presents a review of the research literature to identify the methodology used and outcome measures derived in the use of accelerometers to measure free-living activity in patients with COPD. Using this and existing empirical validity evidence we further identify standards for use, and recommended clinical outcome measures from continuous accelerometer data to describe pertinent measures of sedentary behaviour and physical activity in this and similar patient populations. We provide measures of the strength of evidence to support our recommendations and identify areas requiring continued research. Our findings support the use of accelerometry in clinical trials to understand and measure treatment-related changes in free-living physical activity and sedentary behaviour in patient populations with limited activity.

AB - This article presents a review of the research literature to identify the methodology used and outcome measures derived in the use of accelerometers to measure free-living activity in patients with COPD. Using this and existing empirical validity evidence we further identify standards for use, and recommended clinical outcome measures from continuous accelerometer data to describe pertinent measures of sedentary behaviour and physical activity in this and similar patient populations. We provide measures of the strength of evidence to support our recommendations and identify areas requiring continued research. Our findings support the use of accelerometry in clinical trials to understand and measure treatment-related changes in free-living physical activity and sedentary behaviour in patient populations with limited activity.

KW - accelerometry

KW - clinical trials

KW - COPD

KW - free-living activity

KW - sedentary behaviour

KW - study design

UR - http://www.scopus.com/inward/record.url?scp=84955492958&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2016.01.006

DO - 10.1016/j.cct.2016.01.006

M3 - Article

VL - 47

SP - 172

EP - 184

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -